The money will fund leading-edge research in robotic surgery, protein identification and other technologies. Because of London's strong health care infrastructure, the city is likely to benefit from the cancer research investment as well, DeCicco said. The funding will help Western continue to attract and retain some of the world's best scientists. The facility will be led by scientists at Western but include the University of Toronto, York University and McMaster University and will focus on the leading-edge research in proteomics.
Proteomics looks at . . .
Many proteins hook or link together with other proteins and, once hooked in, act as either catalysts or inhibitors to certain processes. Its one thing to know about the gene complex, it's another thing to be able to identify and manipulate the actual proteins they produce. The corporate contributors are London-based Liffey Custom Coatings Inc. and Xerox Canada. The technology allows metal to be sprayed with a dry powder to create a strong, protective finish in one application. But in addition to wide-ranging industrial and manufacturing applications, the technology has medical applications as well, Stiller said.